Longaeva Partners’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
Other funds holding KNSA
BBA
Longaeva Partners's KNSA Position: Q3 2026 in Review
Longaeva Partners opened a new position in Kiniksa Pharmaceuticals (KNSA) in Q3 2026: 51,460 shares worth $3.84M. The stake represents 0.08% of the portfolio and ranks #202 among its holdings.
305 funds tracked by Wall St. Rank hold KNSA as of Q3 2026.
- Longaeva Partners held 51,460 shares of Kiniksa Pharmaceuticals worth $3.84M as of Q3 2026.
- Kiniksa Pharmaceuticals was a new Longaeva Partners position in Q3 2026.
- Kiniksa Pharmaceuticals made up 0.08% of Longaeva Partners's portfolio in Q3 2026, its #202 holding.
- 305 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2026.
Based on Longaeva Partners's 13F filing for Q3 2026, filed 16 Nov 2026.